Extensive Stage Lung Small Cell Cancer Clinical Trials

5 clinical trials for Extensive Stage Lung Small Cell Cancer across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer — RECRUITING · PHASE2
• A Trial of Tarlatamab in Patients With Pretreated Extensive-stage Small Cell Lung Cancer (ES-SCLC) and ECOG PS 2 — RECRUITING · PHASE2
• Sintilimab Combined With Tafolecimab and Chemotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer — RECRUITING · PHASE2
• Open-Label, Biomarker-Integrated Umbrella Trial for First-Line Treatment of Extensive-stage Small Cell Lung Cancer — NOT_YET_RECRUITING · PHASE2
• Testing the Addition of Radiation Therapy to the Immune Therapy Treatment for ES-SCLC — OTHER · PHASE2

Refine this search